Sort by
Refine Your Search
-
Listed
-
Category
-
Country
- United States
- Denmark
- Germany
- United Kingdom
- France
- Spain
- Canada
- Mexico
- Luxembourg
- Sweden
- Belgium
- India
- United Arab Emirates
- Australia
- Austria
- Ireland
- Italy
- Singapore
- South Africa
- Finland
- Hong Kong
- Worldwide
- Japan
- Malaysia
- Taiwan
- Qatar
- Norway
- Switzerland
- Brazil
- Czech Republic
- Israel
- Latvia
- Netherlands
- New Zealand
- Portugal
- Slovenia
- South Korea
- 27 more »
- « less
-
Program
-
Field
-
Research Scientist Applications are invited for a Research Scientist to join the Laboratory of Dr Evelien Adriaenssens in the Microbes and Food Safety programme at Quadram Institute Bioscience (QIB
-
), toxicology, drug metabolism, and translational pharmacology. The successful candidate will: Contribute to the development and delivery of the new French-language Doctor of Pharmacy (PharmD) program, and
-
Significance 80 hours of sick time per calendar year Paid Maternity and Parental Leave benefit 401(k) program participation with company matched contributions Employee stock purchase plan Tuition reimbursement
-
, computational and medicinal chemists. Projects will focus on advancing cutting-edge drug discovery programs for childhood catastrophic diseases using the latest approaches in proximity-based targeting
-
will be working closely with experts in next-generation, multi-omic assays and integrative computational analysis to understand immunity in health, disease, and treatment. This work requires broad
-
(CERC) in Regenerative Medicine and Diabetes. The CERC program, Canada’s highest research chair appointment, is designed to attract and support world-renowned researchers and their teams to Canada. It is
-
The Department of Cardiovascular Medicine and the Cardiovascular Research Center at Mayo Clinic are seeking a physician scientist with a major, translational research program. Experience in early
-
-breaking interdisciplinary research program aimed at accelerating prevention, detection, treatment and care of interconnected brain and heart disorders through research co-produced with patients and other
-
Postdoctoral Fellow – Mitochondrial Microproteins & Therapeutic Innovation Lena Ho Lab | Duke-NUS Medical School, Singapore Cardiovascular & Metabolic Disorders Programme Advance scientific
-
in preclinical testing. The core technology has FDA approval for Phase I trials, but needs optimization on the I.P., scale manufacture and antigen production areas. Our plan is to leverage emerging